Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dXvCCfbwocePhznhCPxY

  ADVERTISEMENT  
October 25, 2012
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  Diabetes in Focus 
  • Diabetes with HCV elevates liver-related death risk
    Patients with diabetes and hepatitis C showed a higher mortality risk from malignant and nonmalignant liver-related causes compared with those who had diabetes or HCV alone and healthy controls, researchers reported at the American College of Gastroenterology's annual meeting. However, malignancies that were not related to the liver were associated with fewer deaths among patients with diabetes and HCV than those in the other groups. Healio (10/24) LinkedInFacebookTwitterEmail this Story
  • Dulaglutide outperforms 3 diabetes drugs in Phase III trial
    Data from a late-stage trial revealed the investigational once-weekly diabetes drug dulaglutide fared better than Byetta, oral metformin and Januvia in reducing blood glucose levels in patients. Gastrointestinal-related side effects were noted, but dulaglutide's overall safety profile was similar to findings seen in midstage trials, drugmaker Eli Lilly and Co. stated. Reuters (10/22) LinkedInFacebookTwitterEmail this Story
  Nutrition & Wellness 
  • Lower metabolic syndrome risk is seen with weightlifting
    A study of 5,618 U.S. adults showed that those who lift weights were 37% less likely to develop metabolic syndrome compared with those who do not. Researchers also found that lifting weights was more common in men than in women, and more common among people younger than 50. The findings were published in The Journal of Strength and Conditioning Research. Yahoo/Asian News International (10/24) LinkedInFacebookTwitterEmail this Story
  • Potential to aid black girls is seen in anti-obesity approach
    Family-based obesity interventions showed potential in weight-related behaviors of obese black girls, but the results often were nonsignificant, an analysis in Obesity Reviews revealed. "Study designs that directly compare different types and levels of family involvement and incorporate relevant theoretical elements may be an important next step," researchers noted. PhysiciansBriefing.com/HealthDay News (10/24) LinkedInFacebookTwitterEmail this Story
  Practice Update 
  • HHS pushes back against calls to delay MU program
    Recent calls from four House Republicans to suspend the federal meaningful use effort have received pushback from HHS officials. During a recent conference, National Health IT Coordinator Dr. Farzad Mostashari agreed with advice from the College of Healthcare Information Management Executives, which, in a letter to the legislators, advised patience with the program. CMS official Travis Broome said delaying the MU effort would at least necessitate a revision of the regulation, if not an act of Congress. Healthcare IT News (10/23) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  • Why health care groups need not be afraid of ICD-10
    Health groups should strive to understand ICD-10, rather than see it as a reason for fear, so they can start their preparations earnestly, says Rhonda Buckholtz, vice president of ICD-10 education and training at AAPC. Buckholtz offers five reasons not to fear ICD-10, including that costs are unlikely to escalate, productivity concerns can be avoided strategically and the new codes won't change medical practice. Healthcare IT News (10/22) LinkedInFacebookTwitterEmail this Story
  ADA News 
  • ADA 2013 Kelly West Award for Epidemiology: Call for Nominations
    Now through Nov. 16 (8 p.m. EDT), the American Diabetes Association is seeking nominations for the 2013 Kelly West Award for Epidemiology. Given in memory of Kelly M. West, widely regarded as the "father of diabetes epidemiology," to an individual who has made significant contributions to the field of diabetes epidemiology. The recipient will deliver the 2013 Kelly West Award Lecture at the 73rd Scientific Sessions, June 21 to 25, at McCormick Place Convention Center in Chicago. Learn more and nominate. LinkedInFacebookTwitterEmail this Story
Learn more about DiabetesPro ->DiabetesPro Home  |  Professional Education  |  Journals
Research Grants  |  Recognition Programs  |  Membership

  SmartQuote 
In any field, find the strangest thing and then explore it."
--John Archibald Wheeler,
American theoretical physicist


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information